Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?

被引：20
作者：
Weiner, Louis M. [1 ]
Surana, Rishi [1 ]
Murray, Joseph [1 ]
机构：
[1] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA
来源：
CANCER PREVENTION RESEARCH | 2010年 / 3卷 / 04期
关键词：
FIBROBLAST ACTIVATION PROTEIN; REGULATORY T-CELLS; BREAST-CANCER; MOUSE MODEL; TUMOR; CYCLOOXYGENASE-2; IMMUNOTHERAPY; LYMPHOCYTES; EXPRESSION; INHIBITOR;
D O I：
10.1158/1940-6207.CAPR-10-0040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This perspective on the report by Beatty et al. in this issue of the journal (beginning on page 438) discusses the prevention of cancer through vaccination strategies that target antigens associated with tumor promotion and progression. Such approaches were first developed for treating cancer. We address cancer vaccination in the context of a mouse model of inflammatory bowel disease expressing MUC1, an epithelial mucin aberrantly expressed during chronic inflammation and in colorectal carcinogenesis, and in a broader context that includes the potential of targeting the tumor microenvironment for immunoprevention in humans. Obstacles in developing effective cancer vaccines, including antigen selection, immunoediting, and tumor-mediated immunosuppression, are also discussed. Cancer Prev Res; 3(4); 410-5. (C)2010 AACR.
引用
收藏
页码：410 / 415
页数：6
相关论文
共 45 条
  • [21] A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
    Hussain, S. Farzana
    Kong, Ling-Yuan
    Jordan, Justin
    Conrad, Charles
    Madden, Timothy
    Fokt, Isabella
    Priebe, Waldemar
    Heimberger, Amy B.
    [J]. CANCER RESEARCH, 2007, 67 (20) : 9630 - 9636
  • [22] Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma
    Imai, Hisashi
    Saio, Masanao
    Nonaka, Kenichi
    Suwa, Tatsuhiko
    Umemura, Naoki
    Ouyang, Guan-Feng
    Nakagawa, Jiro
    Tomita, Hiroyuki
    Osada, Shinji
    Sugiyama, Yasuyuki
    Adachi, Yosuke
    Takami, Tsuyoshi
    [J]. CANCER SCIENCE, 2007, 98 (03): : 416 - 423
  • [23] Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells
    Inaba, T
    Sano, H
    Kawahito, Y
    Hla, T
    Akita, K
    Toda, M
    Yamashina, I
    Inoue, M
    Nakada, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) : 2736 - 2741
  • [24] Melan-A-specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4
    Klein, Oliver
    Ebert, Lisa M.
    Nicholaou, Theo
    Browning, Judy
    Russell, Sarah E.
    Zuber, Marina
    Jackson, Heather M.
    Dimopoulos, Nektaria
    Tan, Bee Shin
    Hoos, Axel
    Luescher, Immanuel F.
    Davis, Ian D.
    Chen, Weisan
    Cebon, Jonathan
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2507 - 2513
  • [25] A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells
    Kong, Ling-Yuan
    Wei, Jun
    Sharma, Amit K.
    Barr, Jason
    Abou-Ghazal, Mohamed K.
    Fokt, Izabela
    Weinberg, Jeffrey
    Rao, Ganesh
    Grimm, Elizabeth
    Priebe, Waldemar
    Heimberger, Amy B.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (07) : 1023 - 1032
  • [26] The Epidemiology behind the HPV Vaccine Discovery
    Koutsky, Laura
    [J]. ANNALS OF EPIDEMIOLOGY, 2009, 19 (04) : 239 - 244
  • [27] Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts
    Lee, J
    Fassnacht, M
    Nair, S
    Boczkowski, D
    Gilboa, E
    [J]. CANCER RESEARCH, 2005, 65 (23) : 11156 - 11163
  • [28] Interleukin-10 and the immune response against cancer: a counterpoint
    Mocellin, S
    Marincola, FM
    Young, HA
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 78 (05) : 1043 - 1051
  • [29] Montgomery RB, 2005, CANCER RES, V65, P650
  • [30] Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase
    Muller, Alexander J.
    Sharma, Madhav D.
    Chandler, Phillip R.
    DuHadaway, James B.
    Everhart, Mary E.
    Johnson, Buries A., III
    Kahler, David J.
    Pihkala, Jeanene
    Soler, Alejandro Peralta
    Munn, David H.
    Prendergast, George C.
    Mellor, Andrew L.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (44) : 17073 - 17078
12345